Global Market Report

Global Microbiome Therapeutics Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Feb 13, 2019
  • PAGES：139
  • REPORT CODE：GMM162848
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Driven by the downstream end-users, the market of Microbiome Therapeutics witnessed a growth from XX.00 Million USD in 2014 to XX.00 Million USD in 2018, with a CAGR of XX.00%. Moreover, the forecast of 2019-2026 Microbiome Therapeutics market is offered. The research provides insights for the global Microbiome Therapeutics market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.


    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Microbiome Therapeutics industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.


    The Snapshot of Global Microbiome Therapeutics Market Segmentations:

    By Players:

    • Synthetic Biologics

    • AgBiome

    • Enterome Bioscience

    • Advanced Technology Ventures

    • OpenBiome

    • Second Genome

    • AbbVie

    • C3 Jian

    • Admera Health

    • 4D Pharma

    • AOBiome

    • Osel

    • APC

    • Advancing Bio

    • Ritter Pharmaceuticals

    • Immuron

    • ActoGeniX

    • Seres Therapeutics

    • MicroBiome Therapeutics


    By Types:

    • Fructo-Oligosaccharides

    • Galacto-Oligosaccharides

    • Inulin


    By End-User:

    • Antibiotic-Associated Diarrhoea (AAD)

    • Infectious Childhood Diarrhoea

    • Cholesterol

    • Inflammatory Bowel Disease (IBD)

    • Blood Pressure

    • Lactose Intolerance

    • Weight Loss

    • Vitamin Production

    • Bacterial Vaginosis (BV)

    • Others


    By Regions:

    North America

    • United States

    • Canada

    • Mexico


    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others


    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)


    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others


    Reasons to Purchase the Microbiome Therapeutics Market Report

    • Vertical Market Divisions by Type and End-Users

    • The Most Promising Regions in the Forecast Period

    • Competitive Landscape

    • Key Players’ Strategies and Their Product Offerings

    • Microbiome Therapeutics Market Current Trends/Restraints/Challenges/Opportunities

    • Potential and Niche Market / Regions with Promising Growth

    • Objective Analysis Towards Market Performance

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Microbiome Therapeutics Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Microbiome Therapeutics Market Share by Types

      • 1.3.2 Global Microbiome Therapeutics Market Size and Growth Rate of Fructo-Oligosaccharides from 2014 to 2026

      • 1.3.3 Global Microbiome Therapeutics Market Size and Growth Rate of Galacto-Oligosaccharides from 2014 to 2026

      • 1.3.4 Global Microbiome Therapeutics Market Size and Growth Rate of Inulin from 2014 to 2026

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Microbiome Therapeutics Market Share by End-Users

      • 1.4.2 Global Microbiome Therapeutics Market Size and Growth Rate of Antibiotic-Associated Diarrhoea (AAD) from 2014 to 2026

      • 1.4.3 Global Microbiome Therapeutics Market Size and Growth Rate of Infectious Childhood Diarrhoea from 2014 to 2026

      • 1.4.4 Global Microbiome Therapeutics Market Size and Growth Rate of Cholesterol from 2014 to 2026

      • 1.4.5 Global Microbiome Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (IBD) from 2014 to 2026

      • 1.4.6 Global Microbiome Therapeutics Market Size and Growth Rate of Blood Pressure from 2014 to 2026

      • 1.4.7 Global Microbiome Therapeutics Market Size and Growth Rate of Lactose Intolerance from 2014 to 2026

      • 1.4.8 Global Microbiome Therapeutics Market Size and Growth Rate of Weight Loss from 2014 to 2026

      • 1.4.9 Global Microbiome Therapeutics Market Size and Growth Rate of Vitamin Production from 2014 to 2026

      • 1.4.10 Global Microbiome Therapeutics Market Size and Growth Rate of Bacterial Vaginosis (BV) from 2014 to 2026

      • 1.4.11 Global Microbiome Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.1 United States Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.2 Canada Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.1.3 Mexico Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.1 Germany Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.2 UK Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.3 France Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.4 Italy Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.5 Nordic Countries Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.6 Spain Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.7 BelgiumMicrobiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.8 Poland Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.9 Russia Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.2.10 Turkey Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.1 China Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.2 Japan Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.3 Australia and New Zealand Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.4 India Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.5 ASEAN Countries Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.3.6 South Korea Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Latin America, Middle East & Africa Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.1 GCC Countries Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.2 Brazil Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.3 Nigeria Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.4 South Africa Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

        • 1.5.4.5 Argentina Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026


    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants


    3 Segmentation of Microbiome Therapeutics Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Microbiome Therapeutics by Major Types

      • 3.4.1 Market Size and Growth Rate of Fructo-Oligosaccharides

      • 3.4.2 Market Size and Growth Rate of Galacto-Oligosaccharides

      • 3.4.3 Market Size and Growth Rate of Inulin


    4 Segmentation of Microbiome Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Microbiome Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Microbiome Therapeutics for Antibiotic-Associated Diarrhoea (AAD)

      • 4.4.2 Market Size and Growth Rate of Microbiome Therapeutics for Infectious Childhood Diarrhoea

      • 4.4.3 Market Size and Growth Rate of Microbiome Therapeutics for Cholesterol

      • 4.4.4 Market Size and Growth Rate of Microbiome Therapeutics for Inflammatory Bowel Disease (IBD)

      • 4.4.5 Market Size and Growth Rate of Microbiome Therapeutics for Blood Pressure

      • 4.4.6 Market Size and Growth Rate of Microbiome Therapeutics for Lactose Intolerance

      • 4.4.7 Market Size and Growth Rate of Microbiome Therapeutics for Weight Loss

      • 4.4.8 Market Size and Growth Rate of Microbiome Therapeutics for Vitamin Production

      • 4.4.9 Market Size and Growth Rate of Microbiome Therapeutics for Bacterial Vaginosis (BV)

      • 4.4.10 Market Size and Growth Rate of Microbiome Therapeutics for Others


    5 Market Analysis by Major Regions

    • 5.1 Global Microbiome Therapeutics Production Analysis by Major Regions

    • 5.2 Global Microbiome Therapeutics Consumption Analysis by Major Regions

    • 5.3 Global Microbiome Therapeutics Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Microbiome Therapeutics Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Microbiome Therapeutics Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Microbiome Therapeutics Production, Import, Consumption and Export Analysis


    6 Product Commodity of Microbiome Therapeutics Market in Major Countries

    • 6.1 Top 5 Export Countries in Microbiome Therapeutics market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Microbiome Therapeutics market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Microbiome Therapeutics market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Microbiome Therapeutics market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Microbiome Therapeutics market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Microbiome Therapeutics market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis


    7 North America Microbiome Therapeutics Landscape Analysis

    • 7.1 North America Microbiome Therapeutics Landscape Analysis by Major Types

    • 7.2 North America Microbiome Therapeutics Landscape Analysis by Major End-Users

    • 7.3 North America Microbiome Therapeutics Landscape Analysis by Major Countries

      • 7.3.1 United States Microbiome Therapeutics Market Volume and Growth Rate

      • 7.3.2 Canada Microbiome Therapeutics Market Volume and Growth Rate

      • 7.3.3 Mexico Microbiome Therapeutics Market Volume and Growth Rate


    8 Europe Microbiome Therapeutics Landscape Analysis

    • 8.1 Europe Microbiome Therapeutics Landscape Analysis by Major Types

    • 8.2 Europe Microbiome Therapeutics Landscape Analysis by Major End-Users

    • 8.3 Europe Microbiome Therapeutics Landscape Analysis by Major Countries

      • 8.3.1 Germany Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.2 UK Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.3 France Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.4 Italy Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.6 Spain Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.7 Belgium Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.8 Poland Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.9 Russia Microbiome Therapeutics Market Volume and Growth Rate

      • 8.3.10 Turkey Microbiome Therapeutics Market Volume and Growth Rate


    9 Asia Pacific Microbiome Therapeutics Landscape Analysis

    • 9.1 Asia Pacific Microbiome Therapeutics Landscape Analysis by Major Types

    • 9.2 Asia Pacific Microbiome Therapeutics Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Microbiome Therapeutics Landscape Analysis by Major Countries

      • 9.3.1 China Microbiome Therapeutics Market Volume and Growth Rate

      • 9.3.2 Japan Microbiome Therapeutics Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Microbiome Therapeutics Market Volume and Growth Rate

      • 9.3.4 India Microbiome Therapeutics Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Microbiome Therapeutics Market Volume and Growth Rate

      • 9.3.6 South Korea Microbiome Therapeutics Market Volume and Growth Rate


    10 Latin America, Middle East & Africa Microbiome Therapeutics Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Microbiome Therapeutics Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Microbiome Therapeutics Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Microbiome Therapeutics Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Microbiome Therapeutics Market Volume and Growth Rate

      • 10.3.2 Brazil Microbiome Therapeutics Market Volume and Growth Rate

      • 10.3.3 Nigeria Microbiome Therapeutics Market Volume and Growth Rate

      • 10.3.4 South Africa Microbiome Therapeutics Market Volume and Growth Rate 

      • 10.3.5 Argentina Microbiome Therapeutics Market Volume and Growth Rate

       

    11 Major Players Profile

    • 11.1 Synthetic Biologics

      • 11.1.1 Synthetic Biologics Company Profile and Development Status

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 AgBiome

      • 11.2.1 AgBiome Company Profile and Development Status

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Enterome Bioscience

      • 11.3.1 Enterome Bioscience Company Profile and Development Status

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Advanced Technology Ventures

      • 11.4.1 Advanced Technology Ventures Company Profile and Development Status

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 OpenBiome

      • 11.5.1 OpenBiome Company Profile and Development Status

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Second Genome

      • 11.6.1 Second Genome Company Profile and Development Status

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 AbbVie

      • 11.7.1 AbbVie Company Profile and Development Status

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 C3 Jian

      • 11.8.1 C3 Jian Company Profile and Development Status

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Admera Health

      • 11.9.1 Admera Health Company Profile and Development Status

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 4D Pharma

      • 11.10.1 4D Pharma Company Profile and Development Status

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 AOBiome

      • 11.11.1 AOBiome Company Profile and Development Status

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    • 11.12 Osel

      • 11.12.1 Osel Company Profile and Development Status

      • 11.12.2 Market Performance

      • 11.12.3 Product and Service Introduction

    • 11.13 APC

      • 11.13.1 APC Company Profile and Development Status

      • 11.13.2 Market Performance

      • 11.13.3 Product and Service Introduction

    • 11.14 Advancing Bio

      • 11.14.1 Advancing Bio Company Profile and Development Status

      • 11.14.2 Market Performance

      • 11.14.3 Product and Service Introduction

    • 11.15 Ritter Pharmaceuticals

      • 11.15.1 Ritter Pharmaceuticals Company Profile and Development Status

      • 11.15.2 Market Performance

      • 11.15.3 Product and Service Introduction

    • 11.16 Immuron

      • 11.16.1 Immuron Company Profile and Development Status

      • 11.16.2 Market Performance

      • 11.16.3 Product and Service Introduction

    • 11.17 ActoGeniX

      • 11.17.1 ActoGeniX Company Profile and Development Status

      • 11.17.2 Market Performance

      • 11.17.3 Product and Service Introduction

    • 11.18 Seres Therapeutics

      • 11.18.1 Seres Therapeutics Company Profile and Development Status

      • 11.18.2 Market Performance

      • 11.18.3 Product and Service Introduction

    • 11.19 MicroBiome Therapeutics

      • 11.19.1 MicroBiome Therapeutics Company Profile and Development Status

      • 11.19.2 Market Performance

      • 11.19.3 Product and Service Introduction


    12 Data Source and Research Methodology


    The List of Tables and Figures (Totals 86 Figures and 150 Tables)

    • Figure Product Picture

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Fructo-Oligosaccharides from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Galacto-Oligosaccharides from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Inulin from 2014 to 2026

    • Figure Market Share by Type in 2014

    • Figure Market Share by Type in 2018

    • Figure Market Share by Type in 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Antibiotic-Associated Diarrhoea (AAD) from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Infectious Childhood Diarrhoea from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Cholesterol from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Inflammatory Bowel Disease (IBD) from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Blood Pressure from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Lactose Intolerance from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Weight Loss from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Vitamin Production from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Bacterial Vaginosis (BV) from 2014 to 2026

    • Figure Global Microbiome Therapeutics Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Market Share by End-User in 2014

    • Figure Market Share by End-User in 2018

    • Figure Market Share by End-User in 2026

    • Figure North America Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure United States Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure UK Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure France Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure China Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Australia and New Zealand Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure India Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Countries Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Nigeria Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Microbiome Therapeutics Consumption Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Microbiome Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2018

    • Figure Market Share of TOP 5 Players in 2018

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Microbiome Therapeutics

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Microbiome Therapeutics by Different Types from 2014 to 2026

    • Table Consumption Share of Microbiome Therapeutics by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Fructo-Oligosaccharides

    • Figure Market Size and Growth Rate of Galacto-Oligosaccharides

    • Figure Market Size and Growth Rate of Inulin

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Microbiome Therapeutics by Different End-Users from 2014 to 2026

    • Table Consumption Share of Microbiome Therapeutics by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Antibiotic-Associated Diarrhoea (AAD)

    • Figure Market Size and Growth Rate of Infectious Childhood Diarrhoea

    • Figure Market Size and Growth Rate of Cholesterol

    • Figure Market Size and Growth Rate of Inflammatory Bowel Disease (IBD)

    • Figure Market Size and Growth Rate of Blood Pressure

    • Figure Market Size and Growth Rate of Lactose Intolerance

    • Figure Market Size and Growth Rate of Weight Loss

    • Figure Market Size and Growth Rate of Vitamin Production

    • Figure Market Size and Growth Rate of Bacterial Vaginosis (BV)

    • Figure Market Size and Growth Rate of Others

    • Table Global Microbiome Therapeutics Production by Major Regions

    • Table Global Microbiome Therapeutics Production Share by Major Regions

    • Figure Global Microbiome Therapeutics Production Share by Major Regions in 2014

    • Figure Global Microbiome Therapeutics Production Share by Major Regions in 2018

    • Figure Global Microbiome Therapeutics Production Share by Major Regions in 2026

    • Table Global Microbiome Therapeutics Consumption by Major Regions

    • Table Global Microbiome Therapeutics Consumption Share by Major Regions

    • Figure Global Microbiome Therapeutics Consumption Share by Major Regions in 2014

    • Figure Global Microbiome Therapeutics Consumption Share by Major Regions in 2018

    • Figure Global Microbiome Therapeutics Consumption Share by Major Regions in 2026

    • Table North America Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Europe Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Microbiome Therapeutics Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Microbiome Therapeutics market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Microbiome Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Microbiome Therapeutics market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Microbiome Therapeutics market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table North America Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure North America Microbiome Therapeutics Consumption Share by Types in 2014

    • Figure North America Microbiome Therapeutics Consumption Share by Types in 2018

    • Figure North America Microbiome Therapeutics Consumption Share by Types in 2026

    • Table North America Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table North America Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure North America Microbiome Therapeutics Consumption Share by End-Users in 2014

    • Figure North America Microbiome Therapeutics Consumption Share by End-Users in 2018

    • Figure North America Microbiome Therapeutics Consumption Share by End-Users in 2026

    • Table North America Microbiome Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table North America Microbiome Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Microbiome Therapeutics Consumption Share by Major Countries in 2014

    • Figure North America Microbiome Therapeutics Consumption Share by Major Countries in 2018

    • Figure North America Microbiome Therapeutics Consumption Share by Major Countries in 2026

    • Figure United States Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Europe Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Consumption Share by Types in 2014

    • Figure Europe Microbiome Therapeutics Consumption Share by Types in 2018

    • Figure Europe Microbiome Therapeutics Consumption Share by Types in 2026

    • Table Europe Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Europe Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Consumption Share by End-Users in 2014

    • Figure Europe Microbiome Therapeutics Consumption Share by End-Users in 2018

    • Figure Europe Microbiome Therapeutics Consumption Share by End-Users in 2026

    • Table Europe Microbiome Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Europe Microbiome Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Europe Microbiome Therapeutics Consumption Share by Major Countries in 2014

    • Figure Europe Microbiome Therapeutics Consumption Share by Major Countries in 2018

    • Figure Europe Microbiome Therapeutics Consumption Share by Major Countries in 2026

    • Figure Germany Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure France Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Countries Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Asia Pacific Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by Types in 2014

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by Types in 2018

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by Types in 2026

    • Table Asia Pacific Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Asia Pacific Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by End-Users in 2014

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by End-Users in 2018

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by End-Users in 2026

    • Table Asia Pacific Microbiome Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Microbiome Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by Major Countries in 2014

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by Major Countries in 2018

    • Figure Asia Pacific Microbiome Therapeutics Consumption Share by Major Countries in 2026

    • Figure China Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia and New ZealandMicrobiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure India Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Countries Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Microbiome Therapeutics Consumption by Types from 2014 to 2026

    • Table Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by Types from 2014 to 2026

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by Types in 2014

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by Types in 2018

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Microbiome Therapeutics Consumption by End-Users from 2014 to 2026

    • Table Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by End-Users from 2014 to 2026

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by End-Users in 2014

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by End-Users in 2018

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Microbiome Therapeutics Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by Major Countries from 2014 to 2026

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by Major Countries in 2014

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by Major Countries in 2018

    • Figure Latin America, Middle East & Africa Microbiome Therapeutics Consumption Share by Major Countries in 2026

    • Figure GCC Countries Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Nigeria Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Microbiome Therapeutics Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Synthetic Biologics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Synthetic Biologics

    • Figure Sales and Growth Rate Analysis of Synthetic Biologics

    • Figure Revenue and Market Share Analysis of Synthetic Biologics

    • Table Product and Service Introduction of Synthetic Biologics

    • Table Company Profile and Development Status of AgBiome

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AgBiome

    • Figure Sales and Growth Rate Analysis of AgBiome

    • Figure Revenue and Market Share Analysis of AgBiome

    • Table Product and Service Introduction of AgBiome

    • Table Company Profile and Development Status of Enterome Bioscience

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Enterome Bioscience

    • Figure Sales and Growth Rate Analysis of Enterome Bioscience

    • Figure Revenue and Market Share Analysis of Enterome Bioscience

    • Table Product and Service Introduction of Enterome Bioscience

    • Table Company Profile and Development Status of Advanced Technology Ventures

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advanced Technology Ventures

    • Figure Sales and Growth Rate Analysis of Advanced Technology Ventures

    • Figure Revenue and Market Share Analysis of Advanced Technology Ventures

    • Table Product and Service Introduction of Advanced Technology Ventures

    • Table Company Profile and Development Status of OpenBiome

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of OpenBiome

    • Figure Sales and Growth Rate Analysis of OpenBiome

    • Figure Revenue and Market Share Analysis of OpenBiome

    • Table Product and Service Introduction of OpenBiome

    • Table Company Profile and Development Status of Second Genome

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Second Genome

    • Figure Sales and Growth Rate Analysis of Second Genome

    • Figure Revenue and Market Share Analysis of Second Genome

    • Table Product and Service Introduction of Second Genome

    • Table Company Profile and Development Status of AbbVie

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AbbVie

    • Figure Sales and Growth Rate Analysis of AbbVie

    • Figure Revenue and Market Share Analysis of AbbVie

    • Table Product and Service Introduction of AbbVie

    • Table Company Profile and Development Status of C3 Jian

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of C3 Jian

    • Figure Sales and Growth Rate Analysis of C3 Jian

    • Figure Revenue and Market Share Analysis of C3 Jian

    • Table Product and Service Introduction of C3 Jian

    • Table Company Profile and Development Status of Admera Health

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Admera Health

    • Figure Sales and Growth Rate Analysis of Admera Health

    • Figure Revenue and Market Share Analysis of Admera Health

    • Table Product and Service Introduction of Admera Health

    • Table Company Profile and Development Status of 4D Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of 4D Pharma

    • Figure Sales and Growth Rate Analysis of 4D Pharma

    • Figure Revenue and Market Share Analysis of 4D Pharma

    • Table Product and Service Introduction of 4D Pharma

    • Table Company Profile and Development Status of AOBiome

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AOBiome

    • Figure Sales and Growth Rate Analysis of AOBiome

    • Figure Revenue and Market Share Analysis of AOBiome

    • Table Product and Service Introduction of AOBiome

    • Table Company Profile and Development Status of Osel

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Osel

    • Figure Sales and Growth Rate Analysis of Osel

    • Figure Revenue and Market Share Analysis of Osel

    • Table Product and Service Introduction of Osel

    • Table Company Profile and Development Status of APC

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of APC

    • Figure Sales and Growth Rate Analysis of APC

    • Figure Revenue and Market Share Analysis of APC

    • Table Product and Service Introduction of APC

    • Table Company Profile and Development Status of Advancing Bio

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Advancing Bio

    • Figure Sales and Growth Rate Analysis of Advancing Bio

    • Figure Revenue and Market Share Analysis of Advancing Bio

    • Table Product and Service Introduction of Advancing Bio

    • Table Company Profile and Development Status of Ritter Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ritter Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Ritter Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Ritter Pharmaceuticals

    • Table Product and Service Introduction of Ritter Pharmaceuticals

    • Table Company Profile and Development Status of Immuron

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immuron

    • Figure Sales and Growth Rate Analysis of Immuron

    • Figure Revenue and Market Share Analysis of Immuron

    • Table Product and Service Introduction of Immuron

    • Table Company Profile and Development Status of ActoGeniX

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ActoGeniX

    • Figure Sales and Growth Rate Analysis of ActoGeniX

    • Figure Revenue and Market Share Analysis of ActoGeniX

    • Table Product and Service Introduction of ActoGeniX

    • Table Company Profile and Development Status of Seres Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seres Therapeutics

    • Figure Sales and Growth Rate Analysis of Seres Therapeutics

    • Figure Revenue and Market Share Analysis of Seres Therapeutics

    • Table Product and Service Introduction of Seres Therapeutics

    • Table Company Profile and Development Status of MicroBiome Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of MicroBiome Therapeutics

    • Figure Sales and Growth Rate Analysis of MicroBiome Therapeutics

    • Figure Revenue and Market Share Analysis of MicroBiome Therapeutics

    • Table Product and Service Introduction of MicroBiome Therapeutics


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US